Theme: Gastroenterology Within Biological Peripheries

Gastroenterology 2020

Gastroenterology 2020

Conference Series Ltd invites gastroenterology expertise, researchers, professors, scientific communities, therapists, counsellors, delegates, students, business professionals and executives to attend the “21st International Conference on Gastroenterology, Hepatology & Endoscopy” which is going to be held on September 17-18, 2020 Osaka, Japan.

Conference series LLC organizes 1000+ Global events inclusive of 300+ Conferences every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members as you can have a look at Conference Series.

Gastroenterology 2020 mainly focuses on the latest diagnostic and therapeutic techniques for gastrointestinal diseases. The agenda aims to provide a forum for all gastroenterologists, internal medicine specialists and hepatologists within the region to exchange ideas, discuss innovative methods and review new developments within the field of gastroenterology. The program addresses the hottest topics as well as new medications on the market and innovative surgical techniques discusses the latest research outcomes and technological advancements in the field and brings together leading gastroenterologists, surgeons, physicians, research scholars, students along with industrial and pharmacy professionals to exchange share their views on critical aspects of gastroenterology research. This gastroenterology conference brings together Presidents and Eminent Personalities to explore opportunities on emerging platforms in the field of gastrointestinal therapeutics.

Session 01: 
Gastrointestinal Disorders and Pregnancy: 
Gastrointestinal disorders include such conditions as constipation, irritable bowel syndrome, haemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer. These are most commonly seen during Pregnancy, due to increased levels of Progesterone. Symptoms like Vomiting, Nausea, Diarrhoea, Heartburn and Gastro Oesophageal Reflux Disease (GERD). Gastrointestinal bleeding and perforation are the rare complications during pregnancy however other symptoms ad disorders may found such as Abdominal Pain in Early Pregnancy, Dyspepsia, Nausea and Vomiting, Hyperemesis gravid arum, Inflammatory Bowel Disease, Pancreatitis etc.
Session 02: 
Genetics and Molecular Biology in Gastroenterology: 
Genetics and Genomics will strongly influence the GIT. Molecular biology has become the integral part of the basic clinical Gastroenterology. A broad spectrum of infectious, inheritable and malignant epithelial duct diseases will currently be studied by molecular ways, together with enzyme chain reaction, crossbreeding and polymer sequence analyses. From common disorders like large intestine cancer, inflammation and multiple polyps; to rare conditions like hereditary injury telangiectasia, information of genomic developments is more and more extremely helpful to doctors and their patients.
Session 03: 
Gastrointestinal Cancer/Liver Diseases and Gene Expression: 
Laparoscopic surgery is done through several small incisions in the abdomen instead of one large one, and it's becoming more widely used for some colon cancers. Gastroenterology have Laparoscopic surgery is also being studied for treating some rectal cancers, but more research is needed to see if it as effective as standard surgery. Hepatocellular carcinoma (HCC) is a leading cause of death worldwide. The global gene expression patterns intrinsic to each tumour were sufficiently distinctive that multiple tumour nodules from the same patient could usually be recognized and distinguished from all the others in the large sample set on the basis of their gene expression patterns alone. Lines of evidence have revealed the existence and importance of cancer stem cells (CSCs) in carcinogenesis in the past decades. They are considered to be the root of cancers, and are responsible for tumour growth.
Session 04: 
Paediatric/Neonatal Gastroenterology and Vitamins/Nutrition: 
Paediatric Gastroenterology is subjected with treating the gastrointestinal tract, liver and pancreas of children from infancy till adulthood. Testing is done using PH Probes, Breath Test, Liver Biopsies, and Endoscopic Procedure. The main aim of the study of paediatric gastroenterology is to scale down infant and child rate of deaths, control the spread of infectious disease, and promote healthy lifestyles for a long disease-free life and aid ease the issue of children and adolescents.
Session 05: 
Veterinary Gastroenterology: 
Animals also get infected with various microorganisms that make them ill. Apart from the regular bout of veterinary gastrointestinal infections, they also get infected with the regular infections which in turn harm humans, especially their owners and kids. The diseases that are passed on from animals to humans are called zoonotic diseases, which often cause an outbreak. Out of numerous types of zoonotic diseases, enteric zoonotic diseases affect the gastrointestinal tract of both animals and humans. Common microorganisms that cause gastric infections include Salmonella, E. coli, and Campylobacter.
Session 06: 
Neuro Gastroenterology: 
Neuro-gastroenterology encircles the study of brain, the gut and their interactions in relevance to the consideration and management of gastrointestinal motility and functional gastro intestinal disorders. Neuro-gastroenterology is associated with complex motility and sensory disorders of the gastrointestinal tract. These conditions include: dysphagia related to ineffective oesophageal motility, gastro oesophageal reflux, cyclic vomiting syndrome, gastroparesis Hirschsprung’s disease, intestinal pseudo-obstruction slow transit constipation and pelvic outlet disorders related to constipation.
Session 07: 
Recent advances in Gastroenterology: 
Gastroenterology has emerged from the backwoods of medical specialties only over the past 20 years. It is Because of massive improvement in the field of diagnosis and treatment. Gastroenterology has undergone binary fission into hepatology and “hollow organ” gastroenterology. Innovations in colorectal cancer screening, capsule endoscopy, cures for hepatitis C and new biologic therapies are some of the recent advances in gastroenterology.
Neurogastroenterology is the study of the brain, the gut, and their interactions with relevance to the understanding and management of gastrointestinal motility and functional gastrointestinal disorders. Precisely, neurogastroenterology targets on the functions, malfunctions, and the malformations of the sympathetic, parasympathetic, and enteric divisions of the digestive tract.Peroral endoscopic myotomy (POEM) was introduced as a new effective therapeutic option for oesophageal achalasia.
Session 08: 
Prevention and Treatment of Hepatitis: 
Hepatitis A, B, C and E virus will resolve on their own by hepatitis infections over several weeks or months. But severe cases of acute hepatitis B can be treated with antiviral drugs such as lamivudine. Chronic hepatitis B and C infections which do not get better on their own after a few months may be treated with antiviral medications such as pegylated interferon injections or oral antivirals such as lamivudine for hepatitis B or ribavirin for hepatitis C. However, ribavairin must be taken with peginterferon in order for it to be an effective treatment against hepatitis C. Although there is no vaccine for hepatitis D, the disease can still be prevented by vaccinating against hepatitis B. Liver transplants may be necessary if the liver is severely damaged.
Session 09:
Advanced Pancreatitis Treatment:
Treatment for pancreatitis generally requires hospitalization. Once your condition is soothed in the hospital and inflammation in the pancreas is controlled, doctors can treat the underlying cause of your pancreatitis. Ordinarily, most pain can be relieved with OTC medications, such as ibuprofen and acetaminophen. Some patients may need narcotics. In a few cases, In the place of blockages, surgery or ERCP may open the blocked ducts or remove part of the pancreas. Major advanced treatments are: Acute pancreatitis treatment, chronic pancreatitis treatment, Natural treatment for pancreatitis, Pancreaticobiliary Endoscopy, Early Detection of Sporadic Pancreatic Cancer, Pancreatic pseudocyst treatment, Feline pancreatitis treatment, Medical breakthroughs in prevention, diagnosis and treatment etc.
Session 10:
Endoscopy and GI Bleeding:
The endoscope is a thin tube-like instrument that has a light and a lens for viewing. It consists of a probe which is used to bounce high-energy sound waves off internal organs in the chest, abdomen, and colon to make a picture. Also called endoscopic ultrasound.
Gastrointestinal bleeding is one of the common complaints of the patients which could be chronic, mild or lethal. Most of the times, GI bleeding is contained by itself, but they are however evaluated to avoid a recurrence and to avoid further progression of infection if any. Upper GI endoscopy is the first step during a GI bleed, if the result rules out any upper GI bleeding, then a colonoscopy is performed to ascertain that the bleeding is in the lower GI tract. Upper GI bleed is usually caused due to peptic ulcers, gastritis, esophageal varices, upper GI cancers or inflammation of the GI.  While the common cause of bleed in the lower GI tract is diverticulosis, colon cancers or colon polyps, IBD, hemorrhoids, or anal fissures. Symptoms include abdominal pain, breathlessness, pale skin, or passing out.
Gastroenterology Market Size:
The size of the global gastrointestinal therapeutics market is expected to reach USD 13.8 billion by 2020, accelerating at a CAGR of 6.5% between 2015-2020. This growth in market size is attributed to numerous factors including increasing consumption of biologics, tentative approval of late stage molecules, development of novel therapies using innovative technologies, and improved diagnostic tools increasing the treatment-seeking population. 
Additionally, a sudden increase in the number of gastric surgeries across the globe is directly impacting the growth of post-surgical gastroparesis cases across the globe, which will directly propel growth within the gastroparesis drugs market over the next few years. Due to this primary growth factor, the global gastroparesis drugs market will increase USD 940 million between 2016-2021, exceeding USD 7.1 billion in market size by the end of the forecast period. Other factors driving the growth of this market include unmet needs in the industry to increase the R&D in the field and the rising cases of diabetes fueling the prevalence of diabetic gastroparesis. Other insights provided within Technavio’s gastroenterology market reports include:
I- Gastroenterology Market Insights:
The increasing consumption of biologics for inflammatory bowel diseases (IBD) will be one of the major factors that will have a positive impact on the growth of the gastrointestinal therapeutics market size in the coming years. The emergence of biosimilars and the adoption of biosimilars as they contain active pharmaceutical ingredients that are identical to their originator biologic compounds and are also less expensive than biologics will gain traction in this market.
The global gastroparesis drugs market will accelerate at a CAGR of 3% between 2017-2021. Fast track approvals and acquisitions to change the phase of the market and the introduction of novel ways for the treatment of gastroparesis symptoms are the emerging trends which will gain traction during the forecast period. These trends will positively impact the market's growth.
The growing preference for minimally invasive (MI) procedures will drive the growth prospects for the global gastrointestinal stents market during the forecast period. Generally, MI surgeries have low-risk complications and other benefits such as reduced costs, shorter hospital stay, faster recovery, lesser pain, fewer post-surgery infections, reduced incision marks, bleeding control, minimal complications, and heightened accuracy.
II- Gastroenterology Market Share and Segmentation:
Within our gastroenterology industry research, we provide deep insights into the gastroenterology market landscape, its segments, and their market share. Our research experts segment the gastroenterology market by tract diseases and organ diseases.
Gastrointestinal Tract Diseases Market
Esophagus disorders market
o Gastroesophageal reflux disease (GERD) market
o Eosinophilic esophagitis market
 Stomach diseases market
o Gastritis market
o Gastroenteritis market
o Gastroparesis market
o Peptic ulcers market
 Colonic diseases market
o Colorectal cancer market
o Colonic polyps’ market
o Ulcerative colitis market
 Small Intestine disorders market
o Celiac disease market
o Crohn's disease market
o Intestinal cancer market
Gastrointestinal Organs Diseases Market
 Liver diseases market
o Hepatitis A market
o Hepatitis B market
o Hepatitis C market
o Wilson disease market
o Cirrhosis market
 Pancreatic diseases market
o Pancreatitis market
o Cystic fibrosis market
 Gallbladder diseases market
o Gallstone pancreatitis market
o Biliary tract disorders market
We at Technavio, with our comprehensive understanding of the gastroenterology market, have been monitoring the latest industry trends and developments to create an in-depth portfolio of gastroenterology market reports. These reports help our clients identify opportunities within the market and develop effective strategies to optimize their market positions. Our gastroenterology market reports offer the following insights::
Gastroenterology market size
Gastroenterology market share
Gastroenterology market trends
Gastroenterology market growth
Gastroenterology market forecast
Gastroenterology market vendor landscape
Gastroenterology industry statistics
III- Gastroenterology Market – Pipeline Clinical Trials:
To access the growth patterns of the different markets under the gastroenterology industry, Technavio closely monitors the developments in clinical trials and the latest developments taking place within the gastroenterology market. Further, to predict the changes taking place within gastroenterology industry reports trials colon cancer, colorectal cancer, gastric cancer, and liver diseases.
Based on our gastroenterology statistics on clinical trials cover all compound types varying from small molecules to biologics and biosimilars along with vaccines. All our reports classify all clinical trial submissions bases on biosimilars and molecular entity. Further, our healthcare experts ensure that our reports cover all phases of development.
IV- Gastroenterology Market Research – Report Catalog:
 Global Crohn’s disease therapies market
 Global cystic fibrosis therapies market
 Gallbladder diseases therapies market
V- Gastroenterology Clinical Trials – Pipeline Analysis Report:
 Pancreatitis - A Pipeline Overview Report
 Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - A Pipeline Analysis Report
 Traveler’s diarrhea - A Pipeline Analysis Report
Gastroenterology Universities Worldwide:
American College of Gastroenterology, USA
American Gastroenterological Association, USA
Texas Gastroenterology Institute, USA
Harvard University, USA
Johns Hopkins University, USA
Maryland School of Medicine, USA
Vermont College of Medicine, USA
Federal Fluminense University, Brazil
Austral University, Argentina
Gastroenterology - Research & Clinical Trials, Canada
Division of Gastroenterology – University of Alberta, Canada
American Academy of Surgery, USA
Trinity Collage Dublin, Ireland
Donetsk Medical University, Ukraine
Tartu University, Estonia
University of Helsinki, Finland
University of Chester, UK
World Gastroenterology Organisation, Austria
European Association for Gastroenterology, Germany
Research Center of Gastroenterology and Hepatology, Romania
European Society of Gastrointestinal Endoscopy, France
United European Gastroenterology, Austria
University of Gothenburg, Sweden
Buda Health Centre, Hungary
University Medical Centre Freiburg, Germany
University of Camerino, Italy
Kazan State Medical University, Russia
Asian Institute of Gastroenterology, India
Institute for Clinical Sciences (SICS), Singapore
Endoscopy Asia, India
Tohoku Research Centre, Japan
Clinical Research Institute of Diabetes in Changsha, China
Mahkota Medical Centre, Malaysia
Bumrungrad Hospital, Thailand
Institute of Gastroenterology, South Korea
Middle East:
Columbia University Middle East Research Centre, Jordan
The King Saudi University, Saudi Arabia
Tehran University of Medical Sciences, Iran
Gastroenterology Research Centers:
Ohio Gastroenterology and Liver Institute, Ohio
Gastrointestinal Health Research, Canada
Gastroenterology Research of America, Texas
German Cancer Research Center
The Rome Foundation, Rome
Centre for Liver and Gastrointestinal Research
SLO Foundation for Liver and Gastrointestinal Research, Netherlands
Asia-Pacific :
Asian Institute of Gastroenterology, Malaysia
Shanghai Institute of Digestive Disease (SIDD), China
Research Center for Hepatology and Gastroenterology, Japan
Middle East:
Harvard Medical School Centre for Global Health Delivery, Dubai
Columbia University Middle East Research Centre, Jordan
Sidra Medical Research Centre, Qatar
Beth Israel Deaconess Medical Center, Israel
Dubai Specialized Medical Centre & Medical Research Labs, Dubai
Gastroenterology and Hepatology Training in the Islamic Republic of Iran, Iran.
Harley Street Medical Centre, UAE
Advanced Centre for Day Care Surgery, UAE
King Faisal Specialist Hospital & Research Centre, Saudi Arabia
Gastroenterology Hospitals:
University of Toledo Medical Center, USA
Digestive and Liver Disease Center of San Antonio, USA
Pacific Internal Medicine Associates, San Francisco
The Johns Hopkins Hospital, USA
Eastside Endoscopy Center, St. Clair Shores, USA
Massachusetts General Hospital,USA
Belgian Society of Gastrointestinal Endoscopy, Belgium
European Society of Gastrointestinal Endoscopy, Germany
European society of Neuogastroenterology & Motility, Belgium
German Society for Digestive and Metabolic Diseases, Germany
Russian Society for Digestive Endoscopy, Russia
Middle East:
Al Zahra Hospital, Dubai
Aleppo University Hospital, Syria
King Hamad University Hospital, Bahrain
American Hospital,Qatar
Belhoul Speciality Hospital, Dubai
King Khalid University Hospital, Riyadh
KIMS Oman Hospital, Oman
Gastroenterology Societies:
The American Society of Colon and Rectal Surgeons, USA
American Society for Gastrointestinal Endoscopy, USA
Atlanta Gastroenterology Associates, USA
British society of Gastroenterology, UK
British society for Paediatric Gastroenterology, Hepatology and Nutrition, UK
Association of Gastroenterologists of Bosnia and Herzegovina, Herzigovina
Ukrainian Association of Endoscopy, Ukraine
Bulgarian Association of Surgeons and Gastroenterologists, Bulgaria
Japanese Society of Gastroenterology, Japan
Hong Kong Society of Gastroenterology, China
Gastroenterological Society of Singapore, Singapore
Chinese Society of Gastroenterology, China
Middle East:
Emirates Gastroenterology & Hepatology Society, UAE
Egyptian Society of Hepatology and Gastroenterology, Egypt
Saudi Gastroenterology Association, Saudi Arabia
Gastroenterology Associations:
American Gastroenterological Association, California
Canadian Association of Gastroenterology (CAG), Canada
National Fibromyalgia & Chronic Pain Association
Indian Association of Surgical Gastroenterology, India
China Anti-Cancer Association, China
The Japanese Gastroenterological Association, Japan
Russian Gastroenterological Association, RGA, Russia
Middle East:
Saudi gastroenterology Association, Saudi Arabia
Israel Gastroenterology Association
Iranian Association of Gastroenterology

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 17-18, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View